Mark Pruzanski

Insider Reports History

Entity
Individual
Location
C/O Intercept Pharmaceuticals, Inc., 18 Desbrosses St., New York, NY
Signature
/s/ Jason A. Keyes, Attorney-in-Fact for Mark Pruzanski, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Pruzanski:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Equillium, Inc. Director Stock Option (right to buy) 20K May 22, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Mark Pruzanski

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EQ Equillium, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 14 -$11.8M 4 Nov 13, 2023 Director
EQ Equillium, Inc. May 22, 2023 1 $0 4 May 23, 2023 Director
EQ Equillium, Inc. May 24, 2022 1 $0 4 May 25, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 30, 2021 2 $39.9K 4 Dec 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Oct 29, 2021 2 $39.1K 4 Nov 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 30, 2021 2 $34.5K 4 Oct 4, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Aug 31, 2021 2 $34.6K 4 Sep 1, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Jul 30, 2021 2 $40.1K 4 Aug 2, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 30, 2021 2 $46.3K 4 Jul 1, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 28, 2021 2 $38.6K 4 Jun 2, 2021 Director
EQ Equillium, Inc. May 26, 2021 1 $0 4 May 28, 2021 Director